Active Ingredient History
Perflutren is a diagnostic drug that is used for the contrast enhancement during echocardiographic. It consists of lipid-coated microspheres filled with octafluoropropane gas. Ultrasound waves make the microspheres resonate and reflect a strong signal to an ultrasound machine. This results in a difference of density between gas-filled bubbles and blood around them and improves contrast of resulting images. Perflutren is used in patients with suboptimal echocardiograms to opacify the left ventricular chamber and improve the delineation of the heart borders. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Heart Diseases (approved 2001)
Abdominal Neoplasms (Phase 1)
Blood Pressure (Phase 2)
Breast Neoplasms (Phase 4)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Renal Cell (Phase 2)
Cardiac Catheterization (Phase 2)
Cardiovascular Diseases (Phase 4)
Carotid Artery Diseases (Phase 2)
Cholangiocarcinoma (Phase 2)
Chronic Exertional Compartment Syndrome (Phase 2/Phase 3)
Coronary Artery Disease (Phase 4)
Crohn Disease (Phase 1/Phase 2)
Drug Interactions (Phase 1)
Echocardiography (Phase 4)
Echocardiography, Stress (Phase 2)
Hamartoma (Early Phase 1)
Healthy Volunteers (Phase 2)
Heart Diseases (Phase 4)
Heart Failure (Phase 2)
Heart Ventricles (Phase 2)
Hypertension (Phase 4)
Hypertension, Pulmonary (Phase 4)
Ischemic Stroke (Phase 1/Phase 2)
Kidney Diseases, Cystic (Phase 2)
Kidney Neoplasms (Phase 4)
Kidney Transplantation (Phase 4)
Livedoid Vasculopathy (Phase 4)
Liver Diseases (Phase 2)
Liver Neoplasms (Phase 1)
Lymphedema (Phase 1)
Macular Degeneration (Phase 2/Phase 3)
Melanoma (Phase 1)
Myocardial Perfusion Imaging (Phase 4)
Neoplasms, Adnexal and Skin Appendage (Early Phase 1)
Osteosarcoma (Early Phase 1)
Ovarian Neoplasms (Phase 1)
Pediatrics (Phase 4)
Pelvic Neoplasms (Phase 1)
Physiology (Phase 1/Phase 2)
Prostatic Neoplasms (Phase 3)
Pulmonary Heart Disease (Phase 4)
Renal Insufficiency, Chronic (Phase 2)
Retinal Detachment (Phase 3)
Retinal Hemorrhage (Phase 2/Phase 3)
Sarcoma (Early Phase 1)
Signs and Symptoms (Phase 4)
Spinal Cord Injuries (Phase 4)
ST Elevation Myocardial Infarction (Phase 2)
Stroke Volume (Phase 4)
Thyroid Neoplasms (Phase 2)
Vesico-Ureteral Reflux (Phase 1/Phase 2)
Vitreoretinopathy, Proliferative (Phase 3)
von Hippel-Lindau Disease (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
